QuarterlyIQ Insights · XOM
Price
Price, valuation, and the composite score on the same time axis. Scroll over the price chart to zoom.
Price
Daily closes. Earnings/event dots inline.
What it's worth (estimated)
A consensus fair price across 7 valuation methods, at three horizons. Current price $148.82. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
Long-thesis check; widest uncertainty.
By method
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Conf. |
|---|---|---|---|---|---|---|
| Peer EV/EBITDA | 12M | $131.24 | 9.1 | 15.49 | TTM | 50 |
| Peer P/FCF | 12M | $80.98 | 18.8 | 4.30 | TTM | 50 |
| Peer P/E | 12M | $109.58 | 18.1 | 6.05 | TTM | 50 |
| Peer P/S | 12M | $141.10 | 1.8 | 76.40 | TTM | 50 |
| PEG | 12M | $77.46 | 12.8 | 6.05 | TTM | 50 |
| Own P/E history | 12M | $85.41 | 14.1 | 6.05 | TTM | 50 |
| triangulated | 12M | $110.63 | 18.1 | 6.11 | Triangulated | 50 |
| Peer P/FCF | 3Y | $26.04 | 18.8 | 1.38 | Hist. CAGR(prov.) | 51 |
| Peer P/E | 3Y | $324.07 | 18.1 | 17.89 | Analyst | 51 |
| Peer P/S | 3Y | $183.17 | 1.8 | 99.17 | Analyst | 51 |
| PEG | 3Y | $229.08 | 12.8 | 17.89 | Analyst | 51 |
| Own P/E history | 3Y | $252.58 | 14.1 | 17.89 | Analyst | 51 |
| Peer P/E | 5Y | $667.66 | 18.1 | 36.86 | Analyst | 66 |
| Peer P/S | 5Y | $217.97 | 1.8 | 118.01 | Analyst | 66 |
| PEG | 5Y | $471.96 | 12.8 | 36.86 | Analyst | 66 |
| Own P/E history | 5Y | $520.38 | 14.1 | 36.86 | Analyst | 66 |
Composite score history
Daily snapshots of the composite. Zero is the dotted line. Above it leans positive.
P/E history
Monthly trailing P/E with quartile reference lines.
Composite score history currently shows a rolling 60-day window. We're extending it back through full coverage and adding a “consensus-then vs. actual-now” overlay (what our valuation estimate said on a past date versus where the price actually landed).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.